Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Regis Yönetim

Yönetim kriter kontrolleri 3/4

Regis' CEO'su Matt Doctor, Dec2021 tarihinde atandı, in görev süresi 2.83 yıldır. in toplam yıllık tazminatı $ 1.84M olup, şirket hissesi ve opsiyonları dahil olmak üzere 32.6% maaş ve 67.4% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.065% ine doğrudan sahiptir ve bu hisseler $ 40.69K değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 2.3 yıl ve 6.5 yıldır.

Anahtar bilgiler

Matt Doctor

İcra Kurulu Başkanı

US$1.8m

Toplam tazminat

CEO maaş yüzdesi	32.6%
CEO görev süresi	2.8yrs
CEO sahipliği	0.06%
Yönetim ortalama görev süresi	2.3yrs
Yönetim Kurulu ortalama görev süresi	6.5yrs

Son yönetim güncellemeleri

Recent updates

Regis Corporation (NYSE:RGS) Analysts Just Trimmed Their Revenue Forecasts By 12%

May 15

Regis EPS misses by $0.69, misses on revenue

May 05

Health Check: How Prudently Does Regis (NYSE:RGS) Use Debt?

Mar 31

Is There An Opportunity With Regis Corporation's (NYSE:RGS) 49% Undervaluation?

Mar 03

Regis Corporation (NYSE:RGS) Released Earnings Last Week And Analysts Lifted Their Price Target To US$11.00

Feb 05

Regis EPS misses by $0.56, misses on revenue

Feb 04

Reflecting on Regis' (NYSE:RGS) Share Price Returns Over The Last Year

Jan 26

Is Regis (NYSE:RGS) Weighed On By Its Debt Load?

Dec 28

If We Are Past The Pandemic, Supercuts Owner Regis Looks Interesting

Dec 03

Should You Review Recent Insider Transactions At Regis Corporation (NYSE:RGS)?

Dec 02

Regis EPS misses by $0.65, misses on revenue

Nov 02

CEO Tazminat Analizi

Matt Doctor'un ücretlendirmesi Regis'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Jun 30 2024	US$2m	US$600k	US$89m
Mar 31 2024	n/a	n/a	-US$7m
Dec 31 2023	n/a	n/a	-US$7m
Sep 30 2023	n/a	n/a	-US$8m
Jun 30 2023	US$2m	US$600k	-US$11m
Mar 31 2023	n/a	n/a	-US$15m
Dec 31 2022	n/a	n/a	-US$37m
Sep 30 2022	n/a	n/a	-US$39m
Jun 30 2022	US$5m	US$463k	-US$46m

Tazminat ve Piyasa: Matt 'nin toplam tazminatı ($USD 1.84M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 677.23K ).

Tazminat ve Kazançlar: Matt 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Matt Doctor (37 yo)

2.8yrs

Görev süresi

US$1,842,007

Tazminat

Mr. Matthew Doctor, also known as Matt, has been the President, Chief Executive Officer and Director of Regis Corporation since May 2022. He served as Interim Chief Executive Officer Regis Corporation sinc...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Matthew Doctor	President	2.8yrs	US$1.84m	0.065% $ 40.7k
Kersten Zupfer	Executive VP & CFO	4.9yrs	US$722.10k	0% $ 0
John Davi	Executive VP & Chief Digital Officer	2.3yrs	US$736.47k	0.042% $ 26.3k
Michelle DeVore	Senior VP & Head of Marketing	2.2yrs	Veri yok	Veri yok
Jim Lain	Executive Vice President of Brand Operations - Supercuts & Cost Cutters	less than a year	US$1.18m	Veri yok
James Suarez	Executive Vice President of Merchandising & Education	2.6yrs	Veri yok	0.19% $ 116.1k
Michael Ferranti	EVP of Brand Operations of SmartStyle	less than a year	Veri yok	0.11% $ 69.7k
David Kunin	Vice President - The Regis Foundation	no data	US$38.52k	Veri yok

2.3yrs

Ortalama Görev Süresi

46.5yo

Ortalama Yaş

Deneyimli Yönetim: RGS 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.3 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Matthew Doctor	President	2.4yrs	US$1.84m	0.065% $ 40.7k
Michael Merriman	Independent Director	13.2yrs	US$90.00k	Veri yok
Margaret Rhoades	Independent Director	9.8yrs	US$85.00k	0% $ 0
Michael Mansbach	Independent Director	3.3yrs	US$70.00k	0% $ 0
Nancy Benacci	Independent Director	1.4yrs	US$70.00k	0% $ 0
David Grissen	Independent Chairman	11yrs	US$70.00k	0% $ 0
Mark Light	Independent Director	11yrs	US$82.50k	0% $ 0
Lockie Andrews	Independent Director	3.1yrs	US$70.00k	0% $ 0

6.5yrs

Ortalama Görev Süresi

64.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: RGS 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 6.5 yıldır).

Regis Yönetim

Yönetim kriter kontrolleri 3/4

Anahtar bilgiler

Son yönetim güncellemeleri

Regis Corporation, Annual General Meeting, Nov 06, 2024

Regis Corporation Announces Executive Changes

Regis Corporation, Annual General Meeting, Oct 24, 2023

Regis Corporation Appoints Ms. Nancy Benaccito the Board of Directors of the Company, Effective May 1, 2023

Regis Corporation, Annual General Meeting, Oct 25, 2022

Regis Corporation appoints Michelle DeVore as Senior Vice President, Head of Marketing

Recent updates

Regis Corporation, Annual General Meeting, Nov 06, 2024

Regis: Focus On Turnaround Not Metrics

Regis Corporation Announces Executive Changes

Regis Corporation to Report Q4, 2024 Results on Aug 28, 2024

Regis: A Compelling Turnaround

Gary Wyetzner Provides Information to Shareholders

Regis Refinancing A Home Run For Shareholders

Regis Corporation to Report Q3, 2024 Results on May 01, 2024

Regis Corporation: Still Attempting A Turnaround

Regis Corporation Reports Impairment for the Second Quarter Ended December 31, 2023

Regis Corporation to Report Q2, 2024 Results on Jan 31, 2024

William Charters Issues Letter to Regis Corporation

Galloway Capital Partners, LLC Issues a Letter to Regis Corporation

NYSE Regulation Determines to Commence Proceedings to Delist Regis' Common Stock from the NYSE

NYSE to Commence Delisting Proceedings Against Regis Corporation

Regis Corporation Announces Reverse Stock Split to Regain Compliance with Minimum Bid Price Requirements

Regis Corporation Announces Reverse Stock Split to Regain Compliance with Minimum Bid Price Requirements

New major risk - Financial data availability

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

New minor risk - Share price stability

Consensus EPS estimates upgraded to US$0.13 loss, revenue downgraded

Regis Corporation to Report Q1, 2024 Results on Nov 01, 2023

Consensus EPS estimates fall by 82%

Regis Corporation, Annual General Meeting, Oct 24, 2023

Regis Corporation Reports Impairment Charges for the Fourth Quarter Ended June 30, 2023

Full year 2023 earnings: EPS exceeds analyst expectations

Regis Corporation to Report Q4, 2023 Results on Aug 23, 2023

Regis Corporation Appoints Ms. Nancy Benaccito the Board of Directors of the Company, Effective May 1, 2023

Regis Corporation Reports Impairment Charges for the Third Quarter Ended March 31, 2023

Third quarter 2023 earnings: EPS exceeds analyst expectations

Second quarter 2023 earnings released: US$0.055 loss per share (vs US$0.11 loss in 2Q 2022)

Regis GAAP EPS of -$0.05, revenue of $60M

Regis Corporation to Report Q2, 2023 Results on Feb 01, 2023

First quarter 2023 earnings released: US$0.04 loss per share (vs US$0.25 loss in 1Q 2022)

Regis Non-GAAP EPS of -$0.02, revenue of $61.9M

Regis Corporation to Report Q1, 2023 Results on Nov 01, 2022

Regis Corporation, Annual General Meeting, Oct 25, 2022

Regis Corporation appoints Michelle DeVore as Senior Vice President, Head of Marketing

Regis Non-GAAP EPS of -$0.07, revenue of $66.1M

Regis Corporation to Report Q4, 2022 Results on Aug 23, 2022

Regis successfully amends credit facility maturity date and term loan amount

SOHAM INC completed the acquisition of Opensalon Pro from Regis Corporation (NYSE : RGS).

Regis Corporation(NYSE:RGS) dropped from Russell Microcap Value Index

SOHAM INC agreed to acquire Opensalon Pro from Regis Corporation (NYSE : RGS) for $39 million.

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Regis Corporation Appoints Matthew Doctor as Chief Executive Officer

Forecast to breakeven in 2023

Regis Corporation Announces Management Appointments

Regis Corporation Announces Impairment Charges for the Second Quarter Ended December 31, 2021

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Chief Development Officer, Executive VP, General Counsel & Secretary Amanda Rusin has left the company

First quarter 2022 earnings released: US$0.28 loss per share (vs US$0.98 loss in 1Q 2021)

High number of new directors

Price target decreased to US$5.75

Full year 2021 earnings released: US$3.15 loss per share (vs US$4.79 loss in FY 2020)

Price target decreased to US$9.25

Regis Corporation (NYSE:RGS) Analysts Just Trimmed Their Revenue Forecasts By 12%

Third quarter 2021 earnings released: US$0.30 loss per share (vs US$2.10 loss in 3Q 2020)

Regis EPS misses by $0.69, misses on revenue

Health Check: How Prudently Does Regis (NYSE:RGS) Use Debt?

Is There An Opportunity With Regis Corporation's (NYSE:RGS) 49% Undervaluation?

New 90-day high: US$12.64

Regis Corporation (NYSE:RGS) Released Earnings Last Week And Analysts Lifted Their Price Target To US$11.00

Second quarter 2021 earnings released: US$0.92 loss per share (vs US$0.27 loss in 2Q 2020)

Earnings beat expectations, revenue disappoints

Regis EPS misses by $0.56, misses on revenue

Regis Corporation to Report Q2, 2021 Results on Feb 04, 2021

New 90-day high: US$11.80

Reflecting on Regis' (NYSE:RGS) Share Price Returns Over The Last Year